is tirzepatide safer than ozempic Comparative safety and side effects of semaglutide and tirzepatide: Implications for clinical decision-making in obesity management Why You Might Tolerate One

Grains At least half of your daily grain intake should be whole grains, such as brown rice, oats, and barley

A 2025 study found that tripling semaglutides dose to 7.2 mg led to roughly 19% weight loss over 72 weeks, compared to 16% at the standard dose, a meaningful gain, though with higher rates of side effects

If your prior authorization is declined, your insurance will not cover the cost of the prescribed medication

Acknowledgements We thank Christopher Rhodes, PhD, for his expert review of the manuscript and helpful discussions

About ACHIEVE-1 and ACHIEVE clinical trial program ACHIEVE-1 (NCT05971940) is a Phase 3, 40-week, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of orforglipron 3 mg, 12 mg and 36 mg as monotherapy to placebo in adults with type 2 diabetes and inadequate glycemic control with diet and exercise alone